Lidoproct (Lidocaine)

Lidocaine blocks voltage‑gated sodium channels on nerve membranes, preventing the rapid influx of sodium ions that initiates an action potential. By stabilising the neuronal membrane, it stops the transmission of pain signals from the treated area, producing a temporary loss of sensation without affecting consciousness.

The appropriate dose of Lidoproct is determined by the prescribing clinician based on the patient’s condition, age, and overall health. Healthcare professionals select the quantity and frequency that best balances analgesic benefit with safety, and patients should follow the exact instructions provided on the prescription label.

Safety data for rectal lidocaine during pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Lidoproct, as the prescriber may decide to avoid or adjust therapy.

To request Lidoproct, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs), and the necessary import documentation.

Lidoproct contains lidocaine, an amide‑type local anesthetic, which typically offers a faster onset and longer duration of numbness than ester‑type agents such as benzocaine. Compared with systemic analgesics, lidocaine provides targeted pain relief with minimal systemic exposure, reducing the risk of gastrointestinal side effects common to oral NSAIDs.

Lidoproct should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the product out of reach of children and avoid exposing it to extreme heat or humidity, which could compromise its stability and efficacy.

Lidoproct is inserted rectally, typically using a gloved finger or an applicator as directed by the prescriber. The patient should lie on their side with knees drawn toward the chest, gently push the suppository into the rectum, and remain in that position for a few minutes to ensure proper placement and absorption.

The most serious risks associated with Lidoproct include systemic toxicity leading to seizures or cardiac arrhythmias, and severe allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience symptoms like uncontrolled shaking, faintness, irregular heartbeat, difficulty breathing, or widespread rash after use.

Lidoproct should be avoided by individuals with a known hypersensitivity to lidocaine or other amide‑type local anesthetics, patients with severe cardiac conduction disorders, and those with significant hepatic impairment that could impair drug metabolism. Consultation with a healthcare professional is essential before use in these populations.